Owing to their pleiotropic metabolic benefits. glucagon-like peptide-1 receptor (GLP-1R) agonists have been successfully utilized for treating metabolic diseases. such as type 2 diabetes and obesity. As part of our efforts in developing long-acting peptide therapeutics. https://www.lodiceelpueblo.com/product-category/face-powder/